Immatics (IMTX) Cash from Discontinued Operations (2019 - 2024)
Immatics (IMTX) posted Cash from Discontinued Operations of 37041845.6 for Q3 2024, down 11.47% sequentially from 33230312.89 in Q3 2023, and down 11.47% YoY from 41841031.88 in Q4 2023.
Powered by 
Analysis
Immatics (IMTX) Cash from Discontinued Operations (2019 - 2024) Analysis & Trends
Immatics has reported Cash from Discontinued Operations for 6 years, with the latest figure at 37041845.6 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Mar 31, 2022 | 122.45 Mn |
| Mar 31, 2021 | 20.09 Mn |
| Sep 30, 2020 | -56.24 Mn |
| Jun 30, 2020 | -292,988.39 |
| Mar 31, 2020 | -12.64 Mn |
| Sep 30, 2019 | 52.66 Mn |